PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $126,000 | -48.8% | 48,961 | -50.3% | 0.00% | – |
| Q4 2020 | $246,000 | -3.1% | 98,530 | -19.8% | 0.00% | – |
| Q3 2020 | $254,000 | -53.5% | 122,914 | -30.3% | 0.00% | -100.0% |
| Q2 2020 | $546,000 | +32.5% | 176,266 | -2.5% | 0.00% | 0.0% |
| Q1 2020 | $412,000 | +564.5% | 180,766 | +956.9% | 0.00% | – |
| Q4 2019 | $62,000 | -62.9% | 17,103 | -51.9% | 0.00% | – |
| Q2 2019 | $167,000 | +13.6% | 35,578 | -19.0% | 0.00% | – |
| Q1 2019 | $147,000 | -58.2% | 43,914 | -66.8% | 0.00% | – |
| Q4 2018 | $352,000 | -54.6% | 132,335 | -4.4% | 0.00% | -100.0% |
| Q3 2018 | $775,000 | -24.6% | 138,464 | -31.7% | 0.00% | 0.0% |
| Q2 2018 | $1,028,000 | -63.7% | 202,743 | -51.2% | 0.00% | -66.7% |
| Q1 2018 | $2,835,000 | +53.2% | 415,736 | +69.5% | 0.00% | +50.0% |
| Q4 2017 | $1,851,000 | +343.9% | 245,217 | +238.4% | 0.00% | – |
| Q3 2017 | $417,000 | – | 72,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |